{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:17:31Z","timestamp":1793143051697,"version":"4.5.0"},"reference-count":46,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypoxic-ischemic syndrome (HIS) and Hypoxic-ischemic encephalopathy (HIE) are conditions that affect term and premature babies, with different pathophysiology and different brain disorders. HIE appears in 1-6 \/ 1000 live births and 26\/1000 live births in developing countries. 15-20% die in the early neonatal period, while surviving babies have severe neurological impairment, including cerebral palsy, epilepsy, visual and hearing impairment, cognitive impairment, intellectual, behavioural, and social disorders. The hypoxic-ischemic event occurs before, during or after birth. The reasons may be related to the mother, the way of birth, the placenta, and the newborn. The criteria for diagnosis of HIE include a combination of perinatal factors, the need for resuscitation, standard neurological examinations, neurophysiological monitoring, neuroimaging methods and biochemical markers. The most effective treatment for HIE is hypothermia in combination with pharmacological therapy. HIE and HIS are problem that still persist in developing countries due to inadequate obstetric care, neonatal resuscitation, and hypothermia. Current and emerging research for HIE examines new markers for early recognition, treatment, and appropriate neuroprotection of high-risk term and premature infants.<\/jats:p>","DOI":"10.2478\/prilozi-2022-0013","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T03:41:17Z","timestamp":1650598877000},"page":"77-84","source":"Crossref","is-referenced-by-count":24,"title":["Hypoxic Ischemic Encephalopathy (HIE) in Term and Preterm Infants"],"prefix":"10.2478","volume":"43","author":[{"given":"Sanja","family":"Ristovska","sequence":"first","affiliation":[{"name":"University Clinic for Gynecology and Obstetrics , Medical Faculty Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhideja","family":"Stomnaroska","sequence":"additional","affiliation":[{"name":"University Clinic for Gynecology and Obstetrics , Medical Faculty Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Danilovski","sequence":"additional","affiliation":[{"name":"Institute for Epidemiology and Medical Statistics, Medical Faculty Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"2026071214253968670_j_prilozi-2022-0013_ref_001","doi-asserted-by":"crossref","unstructured":"1. Shankaran S: Neonatal encephalopathy: treatment with hypothermia. J Neurotrauma 2009; 26(3): 437\u201344310.1089\/neu.2008.0678282832219281415","DOI":"10.1089\/neu.2008.0678"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_002","doi-asserted-by":"crossref","unstructured":"2. Kurinczuk JJ, White-Koning M, Badawi N: Epidemiology of neonatal encephalopathy and hypoxic-ischemic encephalopathy. Early Human Development, 2010; 86(6), 329\u2013338.10.1016\/j.earlhumdev.2010.05.01020554402","DOI":"10.1016\/j.earlhumdev.2010.05.010"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_003","doi-asserted-by":"crossref","unstructured":"3. Namusoke H, Nannyonga MM, Ssebunya R, Nakibuuka VK, Mworozi E: Incidence and short term outcomes of neonates with hypoxic ischemic encephalopathy in a Peri Urban teaching hospital, Uganda: a prospective cohort study. Matern Health Neonatol Perinatol. 2018; 4: 6.10.1186\/s40748-018-0074-4584079029556412","DOI":"10.1186\/s40748-018-0074-4"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_004","doi-asserted-by":"crossref","unstructured":"4. Kurinczuk JJ, White-Koning M, Badawi N: Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010; 86(6): 329\u201338.10.1016\/j.earlhumdev.2010.05.010","DOI":"10.1016\/j.earlhumdev.2010.05.010"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_005","unstructured":"5. Cruz AC, Ceccon ME: Prevalence of asphyxia and perinatal hypoxic-ischemic encephalopathy in term newborns, considering two diagnostic criteria. Journal of Human Growth and Development. 2010; 20(2): 302\u201316."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_006","unstructured":"6. Eghbalian F: Frequency of Hypoxic-Ischemic Encephalopathy among Hospitalized Neonates in West Iran. Iran J Pediatr. 2010; 20(2): 244\u2013245."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_007","doi-asserted-by":"crossref","unstructured":"7. Wang Q, Lv H, Lu B et al.Neonatal hypoxic-ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phase of the injury.J. Matern Fetal Neonatal Med. 2019; 32(21): 3685-3692.10.1080\/14767058.2018.146888129681183","DOI":"10.1080\/14767058.2018.1468881"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_008","unstructured":"8. Groenendaal F, van Bel F. Perinatal asphyxia in term and late preterm infants, Up to date Inc: 2021 [cited 2021 November 22]. Available from: https:\/\/www.uptodate.com"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_009","doi-asserted-by":"crossref","unstructured":"9. van Bel F, Groenendaal F. Birth asphyxia-induced brain damage: the long road to optimal reduction and prevention! Pediatr Med 2020; 3:3-9.","DOI":"10.21037\/pm.2019.11.02"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_010","doi-asserted-by":"crossref","unstructured":"10. Laptook AR: Birth Asphyxia and Hypoxic-Ischemic Brain Injury in the Preterm Infant. Clin Perinatol. 2016 Sep; 43(3): 529\u201345.10.1016\/j.clp.2016.04.01027524452","DOI":"10.1016\/j.clp.2016.04.010"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_011","unstructured":"11. Bala D, Som S, Das S. A Study of Platelet Count as a Marker of Severity of Hypoxic Ischemic Encephalopathy, IOSR Journal of Dental and Medical Sciences 2015 (14), 5 Ver. V: 62-64."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_012","unstructured":"12. Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Neonatal Encephalopathy. Obstet Gynecol 2019."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_013","doi-asserted-by":"crossref","unstructured":"13. Gopagondanahalli KR, Li J, Fahey MC, Hunt RW, Jenkin G, Miller SL and Malhotra A: Preterm Hypoxic\u2013Ischemic Encephalopathy. Front. Pediatr. 2016; 4: 114.","DOI":"10.3389\/fped.2016.00114"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_014","doi-asserted-by":"crossref","unstructured":"14. Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: A review for the Clinician, J.Pediatr. 2015; 169(4): 397\u2013403.10.1001\/jamapediatrics.2014.326925685948","DOI":"10.1001\/jamapediatrics.2014.3269"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_015","doi-asserted-by":"crossref","unstructured":"15. Juul SE, Ferriero DM: Pharmacologic neuroprotective strategies in neonatal brain injury. Clin Perinataol, 2014; 41(1): 119\u2013131.10.1016\/j.clp.2013.09.004392923724524450","DOI":"10.1016\/j.clp.2013.09.004"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_016","unstructured":"16. Sofijanova A, and al. Urgent pediatric procedures, Skopje. PHI University Clinic for Children\u2019s Diseases; 2016, Mask ventilation with pump, 141-155."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_017","doi-asserted-by":"crossref","unstructured":"17. Gilles F, Gressens P, Dammann O, Leviton A: Hypoxia-ischemia is not an antecedent of most preterm brain damage: the illusion of validity. Dev Med Child Neurol. 2018; 60(2): 120\u2013125.10.1111\/dmcn.13483574532028656697","DOI":"10.1111\/dmcn.13483"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_018","doi-asserted-by":"crossref","unstructured":"18. Laptook AR.: Birth asphyxia and hypoxic-ischemic brain injury in the preterm infant. Clinics in Perinatology, 2016; 43(3), 529\u2013545.10.1016\/j.clp.2016.04.010","DOI":"10.1016\/j.clp.2016.04.010"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_019","doi-asserted-by":"crossref","unstructured":"19. Neil JJ, Volpe JJ: Encephalopathy of prematurity: Clinical neurological features, diagnosis, imaging, prognosis, therapy, Volpe\u2019s Neurology of the Newborn, Elsevier. 6th ed. 2017; 425\u2013457.10.1016\/B978-0-323-42876-7.00016-8","DOI":"10.1016\/B978-0-323-42876-7.00016-8"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_020","unstructured":"20. Ambalavanan N, Carlo WA. Hypoxic\u2013Ischemic Encephalopathy, Nelson Textbook of Pediatrics 20th, new York, Boston, London 2016; 838-842."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_021","doi-asserted-by":"crossref","unstructured":"21. Kinney HC, Volpe JJ: Hypoxic-ischemic injury in the term infant: Neuropathology. Volpe\u2019s neurology of the Newborn, Elsevier 6th ed. 2017; 484\u2013499.10.1016\/B978-0-323-42876-7.00018-1","DOI":"10.1016\/B978-0-323-42876-7.00018-1"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_022","doi-asserted-by":"crossref","unstructured":"22. Sarnat HB, Sarnat MS: Neonatal encephalopathy following foetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976; 33(10): 696\u2013705.10.1001\/archneur.1976.00500100030012987769","DOI":"10.1001\/archneur.1976.00500100030012"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_023","doi-asserted-by":"crossref","unstructured":"23. Mrelashvili A, Russ JB, Ferriero DM et al: The Sarnat score for neonatal encephalopathy: looking back and moving forward. Pediatr Res 88, 2020; 824\u2013825.10.1038\/s41390-020-01143-5770455132916680","DOI":"10.1038\/s41390-020-01143-5"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_024","doi-asserted-by":"crossref","unstructured":"24. MacLennan A: A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999; 319(7216): 1054\u20139.10.1136\/bmj.319.7216.1054111684910521205","DOI":"10.1136\/bmj.319.7216.1054"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_025","doi-asserted-by":"crossref","unstructured":"25. Rutherford MA, Supramaniam V, Ederies A, et al: Magnetic resonance imaging of white matter diseases of prematurity. Neuroradiology 2010; 52: 505\u201321.10.1007\/s00234-010-0700-y20422407","DOI":"10.1007\/s00234-010-0700-y"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_026","doi-asserted-by":"crossref","unstructured":"26. Weeke LC, Groenendaal F, Mudigonda K, Blennow M, Lequin MH, Meiners LC, van Haastert IC, Benders MJ, Hallberg B, de Vries LS: A Novel Magnetic Resonance Imaging Score Predicts Neurodevelopmental Outcome After Perinatal Asphyxia and Therapeutic Hypothermia. J Pediatr. 2018; 192: 33\u201340.e2.10.1016\/j.jpeds.2017.09.043574305129246356","DOI":"10.1016\/j.jpeds.2017.09.043"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_027","doi-asserted-by":"crossref","unstructured":"27. Ouwehand S, Smidt LCA, Dudink J, Benders MJNL, de Vries LS, Groenendaal F, van der Aa NE: Predictors of Outcomes in Hypoxic-Ischemic Encephalopathy following Hypothermia: A Meta-Analysis. Neonatology. 2020; 117(4): 411\u2013427.10.1159\/00050551932235122","DOI":"10.1159\/000505519"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_028","doi-asserted-by":"crossref","unstructured":"28. Jiang CM, Yang YH, Chen LQ, Shuai XH, Lu H, Xiang JH, et al: Early amplitude-integrated EEG monitoring 6 h after birth predicts long-term neurodevelopment of asphyxiated late preterm infants. Eur J Pediatr, 2015; 174(8): 1043\u201352.10.1007\/s00431-015-2490-z25727101","DOI":"10.1007\/s00431-015-2490-z"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_029","doi-asserted-by":"crossref","unstructured":"29. Wikstrom S, Pupp IH, Rosen I, Norman E, Fell-man V, Ley D, et al: Early single-channel aEEG\/ EEG predicts outcome in very preterm infants. Acta Paediatr, 2012; 101(7): 719\u201326.10.1111\/j.1651-2227.2012.02677.x343749522530996","DOI":"10.1111\/j.1651-2227.2012.02677.x"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_030","doi-asserted-by":"crossref","unstructured":"30. Dupont TL, Chalak LF, Morriss MC et al: Short-term outcomes of newborns with perinatal acidemia who are not eligible for systemic hypothermia therapy. J Pediatr 2013; 162: 35\u201341.10.1016\/j.jpeds.2012.06.042371252222871488","DOI":"10.1016\/j.jpeds.2012.06.042"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_031","doi-asserted-by":"crossref","unstructured":"31. Andersen M, Andelius TCK, Pedersen MV, Kyng KJ, Henriksen TB: Severity of hypoxic ischemic encephalopathy and heart rate variability in neonates: a systematic review. BMC Pediatr. 2019; 19(1):2 42.","DOI":"10.1186\/s12887-019-1603-7"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_032","doi-asserted-by":"crossref","unstructured":"32. Murray DM: Biomarkers in neonatal hypoxic-ischemic encephalopathy-Review of the literature to date and future directions for research. Handb Clin Neurol. 2019; 162: 281\u2013293.10.1016\/B978-0-444-64029-1.00013-831324315","DOI":"10.1016\/B978-0-444-64029-1.00013-8"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_033","doi-asserted-by":"crossref","unstructured":"33. Ahearne CE, Boylan GB, Murray DM: Short and long term prognosis in perinatal asphyxia: An update. World J Clin Pediatr. 2016; 5(1): 67\u201374.10.5409\/wjcp.v5.i1.67473769526862504","DOI":"10.5409\/wjcp.v5.i1.67"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_034","doi-asserted-by":"crossref","unstructured":"34. Michniewicz B, Szpecht D, Sowi\u0144ska A, Sibiak R, Szymankiewicz M, Gadzinowski J: Biomarkers in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia. Childs Nerv Syst. 2020; 36(12): 2981\u20132988.10.1007\/s00381-020-04645-z764917732367165","DOI":"10.1007\/s00381-020-04645-z"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_035","doi-asserted-by":"crossref","unstructured":"35. Abate BB, Bimerew M, Gebremichael B, Mengesha Kassie A, Kassaw M, Gebremeskel T, et al.: Effects of therapeutic hypothermia on death among asphyxiated neonates with hypoxicischemic encephalopathy: A systematic review and meta-analysis of randomized control trials. PLoS ONE, 2021, 16(2): e0247229.10.1371\/journal.pone.0247229790635033630892","DOI":"10.1371\/journal.pone.0247229"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_036","unstructured":"36. Shankaran S, Pappas A, McDonalds SA, et al: Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl. J Med 2012; 366: 2085\u201392."},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_037","doi-asserted-by":"crossref","unstructured":"37. Lee CYZ, Chakranon P and Lee SWH: Comparative Efficacy and Safety of Neuroprotective Therapies for Neonates With Hypoxic Ischemic Encephalopathy: A Network Meta-Analysis. Front. Pharmacol. 2019, 10: 1221.10.3389\/fphar.2019.01221682425931708771","DOI":"10.3389\/fphar.2019.01221"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_038","doi-asserted-by":"crossref","unstructured":"38. Aly H, Elmahdy H, EI-Dib M, Rowisha M, Awny M, EI-Gohary T, Eibatch M, Mamisa M, EI-Mashad AR: Melatonin use for neuroprotection in perinatal asphyxia: A randomized controlled pilot study. J Perinatol. 2015; 35(3): 186\u2013191.10.1038\/jp.2014.18625393080","DOI":"10.1038\/jp.2014.186"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_039","doi-asserted-by":"crossref","unstructured":"39. Frymoyer A, Juul SE, Massaro AN, et al: High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Pediatr Res 2017; 81: 865\u201372.10.1038\/pr.2017.15547636528099423","DOI":"10.1038\/pr.2017.15"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_040","unstructured":"40. Wu YW, Mathur AM, Chang T, et al: High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial. Pediatrics 2016; 137.10.1542\/peds.2016-019127244862"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_041","doi-asserted-by":"crossref","unstructured":"41. Pazos MR, Mohammed N, Lafuente H, et al: Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology 2013; 71: 282\u201391.10.1016\/j.neuropharm.2013.03.02723587650","DOI":"10.1016\/j.neuropharm.2013.03.027"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_042","doi-asserted-by":"crossref","unstructured":"42. Barks JDE, Liu Y, Wang L, et al: Repurposing azithromycin for neonatal neuroprotection. Pediatr Res 2019; 86: 444\u201351.10.1038\/s41390-019-0408-6676489131100754","DOI":"10.1038\/s41390-019-0408-6"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_043","doi-asserted-by":"crossref","unstructured":"43. Uccelli A, Moretta L, Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726\u201336.10.1038\/nri239519172693","DOI":"10.1038\/nri2395"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_044","doi-asserted-by":"crossref","unstructured":"44. Fleiss B, Guillot PV, Titomanlio L, et al: Stem cell therapy for neonatal brain injury. Clin Perinatol 2014; 41: 133\u201348.10.1016\/j.clp.2013.09.00224524451","DOI":"10.1016\/j.clp.2013.09.002"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_045","doi-asserted-by":"crossref","unstructured":"45. van Velthoven CT, Kavelaars A, van Bel F, et al: Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 2011; 25: 1342\u20138.10.1016\/j.bbi.2011.03.02121473911","DOI":"10.1016\/j.bbi.2011.03.021"},{"key":"2026071214253968670_j_prilozi-2022-0013_ref_046","doi-asserted-by":"crossref","unstructured":"46. Wagenaar N, Nijboer CH, van Bel F: Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice. Dev Med Child Neurol 2017; 59: 997\u20131003.10.1111\/dmcn.1352828786482","DOI":"10.1111\/dmcn.13528"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2022-0013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:47:57Z","timestamp":1783900077000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2022-0013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,22]]},"published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["10.2478\/prilozi-2022-0013"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2022-0013","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}